Trial of Stem Cell-derived Therapy for Parkinson’s to Open in Sweden
A request to launch a first Phase 1/2 clinical trial of a stem cell-based therapy in people with Parkinson’s…
Articles by Margarida Maia, PhD
Dopamine Transporter in Brain May One Day Tell Parkinson’s Severity
Using simulated images, researchers have developed a method that may allow them to quantify how much dopamine transporter — a…
Patients May Show Signs of Disease Years Before Their Diagnosis
People who go on to develop a neurodegenerative disease such as Parkinson’s may experience poorer overall health and show…
Potential Parkinson’s Treatment Focuses on Protecting Mitochondria
Two small molecules in the pipeline of Lucy Therapeutics helped nerve cells (neurons) keep their mitochondria healthier and…
Cannabinoid Mixtures Ease Parkinson’s Motor Symptoms in Zebrafish
Gb Sciences has identified a handful of mixtures that contain just enough  cannabinoids — the active compounds of the…
Dosing Begins for Phase 3 LIGHTHOUSE Study of BIIB122
Dosing has begun in LIGHTHOUSE, a Phase 3 clinical trial testing BIIB122 — an experimental inhibitor of LRRK2 being developed…
Turning Words Into Actions May Improve Memory
Acting out a word or phrase may help people keep memory of it — a phenomenon called the enactment effect…
Rapid Skin Swab Test May Help Diagnose Parkinson’s
A non-invasive skin swab test may make a diagnosis of Parkinson’s disease in as few as three minutes, according…
Dosing Completed in Parkinson’s-related Bradykinesia Stem Cell Trial
IMAC Holdings has completed the dosing of a third and last group of patients who are taking part in…
Dosing Begins in Phase 2a Trial of Oral Treatment to Aid Cognition
Patient dosing has begun in a Phase 2a clinical trial testing oral CST-2032 in combination with CST-107 as a potential…